Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04235101
Title Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Byondis B.V.

endometrial carcinoma

uterine carcinosarcoma

ovarian cancer

breast cancer

Advanced Solid Tumor


Niraparib + Trastuzumab Duocarmazine

Age Groups: adult | senior
Covered Countries BEL

No variant requirements are available.